Latest Insider Transactions at Jazz Pharmaceuticals PLC (JAZZ)
This section provides a real-time view of insider transactions for Jazz Pharmaceuticals PLC (JAZZ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Jazz Pharmaceuticals plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Jazz Pharmaceuticals plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2021
|
Neena M Patil EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,270
+21.31%
|
-
|
|
Feb 25
2021
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,160
+19.13%
|
-
|
|
Feb 25
2021
|
Kim Sablich EVP, GM of U.S. |
BUY
Grant, award, or other acquisition
|
Direct |
8,535
+25.2%
|
-
|
|
Feb 25
2021
|
Daniel N Swisher Jr President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
11,695
+17.89%
|
-
|
|
Feb 03
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
250
-0.08%
|
$40,000
$160.0 P/Share
|
|
Feb 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,250
-0.39%
|
$195,000
$156.15 P/Share
|
|
Jan 04
2021
|
Daniel N Swisher Jr President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,607
-3.69%
|
$257,120
$160.4 P/Share
|
|
Jan 04
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
7,950
-2.43%
|
$1,287,900
$162.01 P/Share
|
|
Dec 04
2020
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
62
-0.99%
|
$9,424
$152.55 P/Share
|
|
Dec 03
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
250
-0.08%
|
$37,500
$150.0 P/Share
|
|
Dec 01
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.3%
|
$140,000
$140.58 P/Share
|
|
Nov 12
2020
|
Patrick G Enright Director |
SELL
Open market or private sale
|
Direct |
9,929
-12.26%
|
$1,449,634
$146.81 P/Share
|
|
Nov 06
2020
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
197
-1.39%
|
$29,747
$151.93 P/Share
|
|
Nov 05
2020
|
Kenneth W O'Keefe Director |
SELL
Open market or private sale
|
Direct |
11,000
-10.78%
|
$1,694,000
$154.47 P/Share
|
|
Nov 04
2020
|
Catherine A. Sohn Director |
SELL
Open market or private sale
|
Direct |
12,500
-36.36%
|
$1,925,000
$154.0 P/Share
|
|
Nov 04
2020
|
Catherine A. Sohn Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+26.49%
|
$800,000
$64.3 P/Share
|
|
Nov 04
2020
|
Paul L Berns Director |
SELL
Open market or private sale
|
Direct |
4,691
-11.43%
|
$698,959
$149.21 P/Share
|
|
Nov 03
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,500
-0.75%
|
$385,000
$154.0 P/Share
|
|
Nov 02
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.3%
|
$145,000
$145.13 P/Share
|
|
Nov 02
2020
|
Patrick G Enright Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,929
+24.68%
|
-
|
|
Nov 02
2020
|
Kenneth W O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
22,249
+42.86%
|
-
|
|
Nov 02
2020
|
Paul L Berns Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,691
+24.53%
|
-
|
|
Oct 01
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
4,500
-1.34%
|
$634,500
$141.94 P/Share
|